BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 25661697)

  • 21. Between- and within-group effects of alcohol and cannabis co-use on AUD/CUD in the NSDUH 2002-2019.
    Waddell JT
    Drug Alcohol Depend; 2021 Aug; 225():108768. PubMed ID: 34049100
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bipolar disorder and co-occurring cannabis use disorders: characteristics, co-morbidities and clinical correlates.
    Lev-Ran S; Le Foll B; McKenzie K; George TP; Rehm J
    Psychiatry Res; 2013 Oct; 209(3):459-65. PubMed ID: 23312479
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sensitivity and specificity of S2BI for identifying alcohol and cannabis use disorders among adolescents presenting for primary care.
    Levy S; Weitzman ER; Marin AC; Magane KM; Wisk LE; Shrier LA
    Subst Abus; 2021; 42(3):388-395. PubMed ID: 32814009
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gender differences in health-related quality of life among cannabis users: results from the National Epidemiologic Survey on Alcohol and Related Conditions.
    Lev-Ran S; Imtiaz S; Taylor BJ; Shield KD; Rehm J; Le Foll B
    Drug Alcohol Depend; 2012 Jun; 123(1-3):190-200. PubMed ID: 22143039
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Associations of alcohol use disorder, cannabis use disorder, and nicotine dependence with concurrent opioid use disorder in U.S. adults.
    Harton MR; Adams ZW; Parker MA
    Exp Clin Psychopharmacol; 2023 Dec; 31(6):998-1004. PubMed ID: 37166911
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Threat Responsiveness as a Function of Cannabis and Alcohol Use Disorder Severity.
    Blair RJR; White SF; Tyler PM; Johnson K; Lukoff J; Thornton LC; Leiker EK; Filbey F; Dobbertin M; Blair KS
    J Child Adolesc Psychopharmacol; 2019 Aug; 29(7):526-534. PubMed ID: 31170004
    [No Abstract]   [Full Text] [Related]  

  • 27. DSM-5 cannabis use disorder, substance use and DSM-5 specific substance-use disorders: Evaluating comorbidity in a population-based sample.
    Hayley AC; Stough C; Downey LA
    Eur Neuropsychopharmacol; 2017 Aug; 27(8):732-743. PubMed ID: 28663122
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative associations of problematic alcohol and cannabis use with suicidal behavior in U.S. military veterans: A population-based study.
    Hill ML; Nichter B; Loflin M; Norman SB; Pietrzak RH
    J Psychiatr Res; 2021 Mar; 135():135-142. PubMed ID: 33477057
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Problem alcohol use and healthcare utilization among persons with cannabis use disorder in the United States.
    John WS; Wu LT
    Drug Alcohol Depend; 2017 Sep; 178():477-484. PubMed ID: 28711814
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Childhood interpersonal violence and adult alcohol, cannabis, and tobacco use disorders: variation by race/ethnicity?
    Meyers JL; Sartor CE; Werner KB; Koenen KC; Grant BF; Hasin D
    Psychol Med; 2018 Jul; 48(9):1540-1550. PubMed ID: 29310741
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Associations of parental alcohol use disorders and parental separation with offspring initiation of alcohol, cigarette and cannabis use and sexual debut in high-risk families.
    McCutcheon VV; Agrawal A; Kuo SI; Su J; Dick DM; Meyers JL; Edenberg HJ; Nurnberger JI; Kramer JR; Kuperman S; Schuckit MA; Hesselbrock VM; Brooks A; Porjesz B; Bucholz KK
    Addiction; 2018 Feb; 113(2):336-345. PubMed ID: 28804966
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prediction of incidence and stability of alcohol use disorders by latent internalizing psychopathology risk profiles in adolescence and young adulthood.
    Behrendt S; Bühringer G; Höfler M; Lieb R; Beesdo-Baum K
    Drug Alcohol Depend; 2017 Oct; 179():32-41. PubMed ID: 28750254
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Demographic and clinical characteristics associated with comorbid cannabis use disorders (CUDs) in hospitalized patients with bipolar I disorder.
    Weinstock LM; Gaudiano BA; Wenze SJ; Epstein-Lubow G; Miller IW
    Compr Psychiatry; 2016 Feb; 65():57-62. PubMed ID: 26773991
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differences in child and adult biopsychosocial characteristics associated with regular cannabis use in individuals with and without cannabis use disorder.
    Foster KT; Arterberry BJ; Zucker RA; Hicks BM
    Drug Alcohol Depend; 2021 Sep; 226():108887. PubMed ID: 34216859
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence, incidence, recovery, and recurrence of alcohol use disorders from childhood to age 30.
    Seeley JR; Farmer RF; Kosty DB; Gau JM
    Drug Alcohol Depend; 2019 Jan; 194():45-50. PubMed ID: 30399499
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The relevance of age at first alcohol and nicotine use for initiation of cannabis use and progression to cannabis use disorders.
    Behrendt S; Beesdo-Baum K; Höfler M; Perkonigg A; Bühringer G; Lieb R; Wittchen HU
    Drug Alcohol Depend; 2012 Jun; 123(1-3):48-56. PubMed ID: 22071122
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential dysfunctions related to alcohol and cannabis use disorder symptoms in reward and error-processing neuro-circuitries in adolescents.
    Aloi J; Meffert H; White SF; Blair KS; Hwang S; Tyler PM; Thornton LC; Crum KI; Adams KO; Killanin AD; Filbey F; Pope K; Blair RJR
    Dev Cogn Neurosci; 2019 Apr; 36():100618. PubMed ID: 30710868
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predicting Persistent, Limited, and Delayed Problematic Cannabis Use in Early Adulthood: Findings From a Longitudinal Study.
    Hill S; Shanahan L; Costello EJ; Copeland W
    J Am Acad Child Adolesc Psychiatry; 2017 Nov; 56(11):966-974.e4. PubMed ID: 29096779
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Specific impact of stimulant, alcohol and cannabis use disorders on first-episode psychosis: 2-year functional and symptomatic outcomes.
    Ouellet-Plamondon C; Abdel-Baki A; Salvat É; Potvin S
    Psychol Med; 2017 Oct; 47(14):2461-2471. PubMed ID: 28424105
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The prevalence of Healthcare Effectiveness Data and Information Set (HEDIS) initiation and engagement in treatment among patients with cannabis use disorders in 7 US health systems.
    Lapham GT; Campbell CI; Yarborough BJH; Hechter RC; Ahmedani BK; Haller IV; Kline-Simon AH; Satre DD; Loree AM; Weisner C; Binswanger IA
    Subst Abus; 2019; 40(3):268-277. PubMed ID: 30657438
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.